Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1994 1
1995 1
1997 1
2004 2
2007 2
2008 4
2009 3
2010 2
2011 3
2012 1
2013 7
2014 2
2015 9
2016 5
2017 13
2018 15
2019 9
2020 26
2021 35
2022 43
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

164 results
Results by year
Filters applied: . Clear all
Page 1
Consensus Paper: Ataxic Gait.
Cabaraux P, Agrawal SK, Cai H, Calabro RS, Casali C, Damm L, Doss S, Habas C, Horn AKE, Ilg W, Louis ED, Mitoma H, Monaco V, Petracca M, Ranavolo A, Rao AK, Ruggieri S, Schirinzi T, Serrao M, Summa S, Strupp M, Surgent O, Synofzik M, Tao S, Terasi H, Torres-Russotto D, Travers B, Roper JA, Manto M. Cabaraux P, et al. Among authors: petracca m. Cerebellum. 2022 Apr 12. doi: 10.1007/s12311-022-01373-9. Online ahead of print. Cerebellum. 2022. PMID: 35414041
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Fox E, Lovett-Racke AE, Gormley M, Liu Y, Petracca M, Cocozza S, Shubin R, Wray S, Weiss MS, Bosco JA, Power SA, Mok K, Inglese M. Fox E, et al. Among authors: petracca m. Mult Scler. 2021 Mar;27(3):420-429. doi: 10.1177/1352458520918375. Epub 2020 Apr 30. Mult Scler. 2021. PMID: 32351164 Free PMC article. Clinical Trial.
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Iaffaldano P, Lucisano G, Manni A, Paolicelli D, Patti F, Capobianco M, Brescia Morra V, Sola P, Pesci I, Lus G, De Luca G, Lugaresi A, Cavalla P, Montepietra S, Maniscalco GT, Granella F, Ragonese P, Vianello M, Brambilla L, Totaro R, Toscano S, Malucchi S, Petracca M, Moiola L, Ferraro D, Lepore V, Mosconi P, Ponzio M, Tedeschi G, Comi G, Battaglia MA, Filippi M, Amato MP, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: petracca m. Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35046084 Free PMC article.
Correction to: Consensus Paper: Ataxic Gait.
Cabaraux P, Agrawal SK, Cai H, Calabro RS, Casali C, Damm L, Doss S, Habas C, Horn AKE, Ilg W, Louis ED, Mitoma H, Monaco V, Petracca M, Ranavolo A, Rao AK, Ruggieri S, Schirinzi T, Serrao M, Summa S, Strupp M, Surgent O, Synofzik M, Tao S, Terasi H, Torres-Russotto D, Travers B, Roper JA, Manto M. Cabaraux P, et al. Among authors: petracca m. Cerebellum. 2022 May 10. doi: 10.1007/s12311-022-01413-4. Online ahead of print. Cerebellum. 2022. PMID: 35536510 No abstract available.
Sodium MRI of multiple sclerosis.
Petracca M, Fleysher L, Oesingmann N, Inglese M. Petracca M, et al. NMR Biomed. 2016 Feb;29(2):153-61. doi: 10.1002/nbm.3289. Epub 2015 Apr 6. NMR Biomed. 2016. PMID: 25851455 Free PMC article. Review.
Quantitative MRI in Multiple Sclerosis: From Theory to Application.
Tranfa M, Pontillo G, Petracca M, Brunetti A, Tedeschi E, Palma G, Cocozza S. Tranfa M, et al. Among authors: petracca m. AJNR Am J Neuroradiol. 2022 Dec;43(12):1688-1695. doi: 10.3174/ajnr.A7536. Epub 2022 Jun 9. AJNR Am J Neuroradiol. 2022. PMID: 35680161 Review.
MRI in multiple sclerosis: clinical and research update.
Inglese M, Petracca M. Inglese M, et al. Among authors: petracca m. Curr Opin Neurol. 2018 Jun;31(3):249-255. doi: 10.1097/WCO.0000000000000559. Curr Opin Neurol. 2018. PMID: 29561520 Review.
164 results